Drug-Induced Immune Neutropenia

Transfusion Medicine Reviews

Volumn 7, Issue 4, 1993, Pages 268-274

  Stroncek, David F ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; ANTITHYROID AGENT; DRUG ANTIBODY; GRANULOCYTE ANTIBODY; PENICILLIN DERIVATIVE;

ANTIGEN RECOGNITION; CLINICAL FEATURE; CYTOPENIA; DISEASE COURSE; DRUG INDUCED DISEASE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; PROGNOSIS; REVIEW;

EID: 0027518064     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(93)70146-7     Document Type: Article

References (58)

1. Aprindine-induced agranulocytosis: Evidence for immunologic mechanism
2. Flecanide-induced immune neutropenia. Documentation of a heptenmediated mechanism of cell destruction
3. Drug-induced immunological neutropenia
4. Evidence for granulocyte antibody activity in two cases of procainamideassociated neutropenia
5. The use of in vitro techniques to study drug-induced pancytopenia
6. Quinidine-induced agranulocytosis
7. Quinidine-induced neutropenia: Report of a case with drug-dependent inhibition of granulocyte colony generation
8. Quinidine-induced thrombocytopenia and leukopenia: Demonstration and characterization of distinct antiplatelet and antileukocyte antibodies
9. Quinidine-induced agranulocytosis
10. Neutropenia due to β lactam antibodies
11. Agranulocytosis during antibiotic therapy: Drug sensitivity or sepsis?
12. Cephadrineassociated neutropenia
13. Cephalosporin-induced immune neutropenia
14. Immune-mediated agranulocytosis related to drugs and their metabolites: Mode of sensitization and heterogeneity of antibodies
15. Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia
16. Prevalence, nature and identification of leukocyte antibodies
17. Amodiaquine-induced immune agranulocytosis
18. Amodiaquineinduced agranulocytosis: Drug inhibition of myeloid colonies in the presence of patient's serum
19. Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolyticuremic syndrome and immune agranulocytosis
20. The role of leukocyte and platelet antibody tests in the management of diverse clinical disorders
21. Agranulocytosis due to the occurrence of leukocyte-agglutinins
22. Elude dum anticorps allergique actif en presence de para-amino-salicylate de soude (PAS) coutre les hematies, les leukocytes et les plaquettes humaines
23. Ibuprofenassociated pure white cell aplasia
24. Immunological granulocytopenia and agranulocytosis
25. An anti-neutrophil antibody associated with a propylthiouracil-induced lupus like syndrome
26. Agranulocytosis induced by propylthiouracil: Evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells
27. Graves’ disease with neutropenia and marked splenomegaly: Autoimmune neutropenia due to propylthiouracil
28. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves’ disease: A possible cause of antithyroid drug induced agranulocytosis
29. Immunological reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs
30. Granulocytotoxic antibodies in a patient with propylthiouracil induced agranulocytosis
31. Chlorpropamide-induced pure white cell aplasia
32. Agranulocytosis caused by chloropropamide
33. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis
34. Studies on levamisole-induced agranulocytosis
35. Levamisoleassociated neutropenia and autoimmune granulocytotoxins
36. Drug-induced agranulocytosis: In vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibody
37. Anti-granulocyte antibodies and deranged immune function associated with phenytoin-induced serum sickness
38. Vancomycin-dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia
39. Neutropenia associated with Vancomycin therapy
40. High incidence of Vancomycinassociated leukopenia and neutropenia in a cardiothoracic surgical unit
41. Agranulocytosis during treatment with mefloquine
42. Quinine-associated immune thrombocytopenia, neutropenia, and renal failure in a patient with Klinefelter's syndrome
43. Quinine-dependent antibodies to neutrophils react with a 60 kD glycoprotein on which NBI antigen is located and an 85 kD glycosylphosphatidylinositol linked N-glycosylated plasma membrane glycoprotein
44. Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets
45. Drug-induced neutropenia—A survey for Stockholm 1973–1978
46. The International Granulocytosis and Aplastic Anemia Study. Risks of granulocytosis and aplastic anemia
47. Treatment of drug-induced agranulocytosis with granulocyte colony stimulating factor
48. Colony-stimulating factor and drug-induced agranulocytosis
49. Methimazole-induced agranulocytosis and granulocyte colony stimulating factor
50. Treatment of drug-induced agranulocytosis with recombinant GM-CSF
51. GM-CSF for agranulocytosis
52. Granulocyte macrophage colony stimulating factor for the treatment of drug induced agranulocytosis
53. Immune mediated blood cell dyscrasias related to drugs
54. Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: A new clinical entity
55. Antiendothelial cell antibodies in plasma of patients with quinine-induced hemolyticuremic syndrome
56. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies
57. Location of the granulocytespecific antigen LAN on the Fe-receptor III